Mazankowski Alberta Heart Institute (MAHI) EchoGo Discovery 1 Protocol

计划入组 250 人 · 首次发布于 2021 年 5 月 7 日

Vyndaqel Capsules Special Investigation (ATTR-CM)

计划入组 1,214 人 · 首次发布于 2019 年 9 月 27 日

Using Ultromics EchoGo HFpEF Algorithm to Identify and Treat High Heart Failure Risk in Patients With Type 2 Diabetes

计划入组 800 人 · 首次发布于 2024 年 9 月 19 日

amyloidosis therapy, orphanbiotec

X-Synergy®

NanoLithium® NP03

GENOMIC HEALTH, INC.

United States

Theralase Technologies Inc

Canada

BLUE ECHO CARE LLC

United States

Ultromics' EchoGo® Amyloidosis Receives FDA Clearance for Cardiac Amyloidosis Detection

Ultromics' EchoGo® Amyloidosis Receives FDA Clearance for Cardiac Amyloidosis Detection

FDA Clears AI-Powered Ultrasound Software EchoGo® Amyloidosis for Enhanced Cardiac Amyloidosis Detection